Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

13.92
+1.037.99%
Post-market: 13.60-0.3200-2.30%17:27 EDT
Volume:86.29K
Turnover:1.19M
Market Cap:201.50M
PE:0.12
High:13.96
Open:13.11
Low:13.11
Close:12.89
Loading ...
Jun 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 03, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 31, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Correspondence

Form CORRESP - Correspondence
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Correspondence

Form CORRESP - Correspondence
Mar 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities